Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2017
Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patientsD M W Balak, E Hajdarbegovic, W M Bramer, et al.
The British Journal of Dermatology|July 22, 2014
Addition of an oral histamine antagonist to reduce adverse events associated with fumaric acid esters in the treatment of psoriasis: a randomized double-blind placebo-controlled trialD M W Balak, S Fallah-Arani, C M Venema, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 5, 2013
Treatment of psoriasis with non-registered fumaric acid esters in The Netherlands: a nationwide survey among Dutch dermatologistsS Fallah Arani, D M W Balak, H A M Neumann, et al.
The British Journal of Dermatology|June 7, 2013
Effectiveness and safety of fumaric acid esters in children with psoriasis: a retrospective analysis of 14 patients from The NetherlandsD M W Balak, A M Oostveen, M T Bousema, et al.
The British Journal of Dermatology|February 28, 2016
Efficacy, effectiveness and safety of fumaric acid esters in the treatment of psoriasis: a systematic review of randomized and observational studiesD M W Balak, S Fallah Arani, E Hajdarbegovic, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 4, 2022
Definitions of remission in psoriasis: a systematic literature review from the National Psoriasis FoundationD M W Balak, L M Perez-Chada, L N Guo, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 19, 2012
Prenatal diagnosis for haemophilia: a nationwide survey among female carriers in the NetherlandsD M W Balak, S C Gouw, I Plug, et al.
The British Journal of Dermatology|May 24, 2014
Regulated genes in psoriatic skin during treatment with fumaric acid estersA J Onderdijk, D M W Balak, E M Baerveldt, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2026
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluationN G Koster, J M P A van den Reek, E M G J de Jong, et al.
Pageof 1